POST EVENT REPORT November 2012, Mumbai, India

Transcription

1 POST EVENT REPORT November 2012, Mumbai, India Direct face-to-face contact with senior level executives & decision makers Extensive corporate branding opportunities & unique marketing platforms targeted at industrial players of India Showcase unique portfolio of products & services Establish thought leadership & brand presence in one of Asia s largest emerging markets India Network & build rapport with NEW clients & business partners Pre & Post-event business development lead generation

2 Table of Contents Executive Summary... 4 Event at a glance... 5 Conference performance... 7 Participation... 8 The integrated marketing plan Attendee List About Terrapinn 28

3

4 Executive Summary Dear Valued Sponsors, Exhibitors & Partners: It has been a great pleasure to have you at BioPharma India Convention As part of Terrapinn s commitment to customer service, we bring you the BioPharma India Convention 2012 Post Event Report. The purpose of this report is to provide you with valuable information about the marketing of our conferences, the attendee list and provide feedback on the results of the show. You may use this report to better understand your customers - the delegates to the show. The report will also help you better prepare for next year s BioPharma India Convention and provide you with greater insights on the industry demands, in the areas of clinical trials and manufacturing needs of India pharmas and biotechs. BioPharma India Convention was successfully staged at Grand Hyatt in Mumbai from November 2012, attracting a total of 235 industry professionals who convened from India and other parts of Asia, Europe and North America. With more than 50 world-class speakers, attendees heard expert advice, presentations and case studies on the opportunities in India s biopharmaceutical industry. Our newly adopted partnering system and onsite networking assistance were complementary in adding value to the attending business leaders and scientists in meeting their target audience and discuss potential partnerships. The event also showcased the leading pharmaceutical, biotechs, and solution providers that comprise the Indian biomedical market place. We have taken note of our conference attendees feedback to increase allocated time for networking between delegates and exhibitors, as well as to increase the time for presentation to provide ample time for Q&A. One-to-one networking opportunities and valuable face time continue to be an interest for many delegates and they look forward to participation in 2013 to learn more about new technologies and innovative methods to improve biologic manufacturing processes, as well as build knowledge on how to effectively conduct clinical trials in India beginning with clinical trial design right up to post-marketing. As a sponsor of the event, your participation and support in this event is deeply appreciated. Terrapinn is committed to providing an effective platform for the industry and to build upon the success for an even better event in We will continue to conduct research and work closely with industry experts to deliver the definitive event and meeting place for the industry. We look forward to working with you on 2013! Rebecca Koh Project Manager, Life Science Terrapinn Pte Ltd

5 Event at a Glance BIOPHARMA INDIA CONVENTION NOVEMBER 2012 BIOLOGIC MANUFACTURING WORLD INDIA 2012 PHARMA TRIALS WORLD INDIA 2012 India s Visionary Leaders Panel: Maintaining India s status as a leading player in the global landscape through innovations and strategic partnerships Networking morning break & showcase visit Biosimilars Manufacturing Partnership & Collaboration Networking luncheon & showcase visit Cell Line Engineering Biosimilar Trials Networking afternoon break & showcase visit Cell Culture & Development Clinical Trial Management End of Conference Day One Trade Exhibition

6 BIOPHARMA INDIA CONVENTION NOVEMBER 2012 BIOLOGIC MANUFACTURING WORLD INDIA 2012 PHARMA TRIALS WORLD INDIA 2012 Global Visionary Leaders Panel: Successful formulation of business growth and partnership strategies for pharma companies in India Executing pharma R&D projects 20-50% faster Networking morning break & showcase visit Downstream Processing (Part One) Regulations Networking luncheon & showcase visit Downstream Processing (Part Two) Pharmacovigilance & Drug Safety Networking afternoon break & showcase visit Operational Excellence, Scale Up & Purification Patient Recruitment & Data Management End of Conference Day Two Trade Exhibition

7 Conference Performance PROGRAMME BioPharma India Convention 2012 featured two conferences focusing on biologic manufacturing and clinical trials in India, and this comes on the back of India continued leadership positioning as the biologic manufacturing hub in Asia, and in response to a growing interest to conduct clinical trials in India. With an emphasis on back to basics content this year, the conferences hosted an impressive speaker faculty of approximately 50+ expert speakers (with a buyer to vendor ratio) from leading global and Indian pharmas and their service providers, reinforcing BioPharma India Convention s draw and reputation as the most strategic event in India s biomedical industry. The depth and breadth of the conference programme lined-up over the two full days was broadened to incorporate: Plenary and keynote morning sessions which play host to an elite class of commercial business leaders, scientists and convention-breaking biopharma industry gurus Parallel stream sessions that focus on the various manufacturing and clinical trial processes integral to a successful management of a project Focus sessions on business opportunities in biosimilars manufacturing and overcoming regulatory challenges while conducting clinical trials in India Networking sessions strategically distributed throughout the day s events to allow interactive discussions with presenting speakers and exploration of potential collaboration The conference agenda brought together a varied audience of manufacturing and clinical trial industry stakeholders, and was generally well received by our 200+ strong audience.

8 Participation The event saw an increase in attendance of approximately 13.5%, and this could be attributed to an increase in exhibitor participation as well as co-location of a Pharma Trials conference. As per past events, BioPharma India saw a strong attendance of India-based conference delegates, with continued participation from representatives in Asia, Europe and US. Pharma & Biotechs remain the key attendee profile at this conference, with new representation of attendees from Merck India, Hetero Drugs, Shashun Pharmaceuticals and Abbott India.

9 BioPharma India Convention 2012 brought together many notable industry leaders of the India biopharmaceutical sector, and approximately 44% of attendees were Director levels and above.

10 The Integrated Marketing Plan OVERVIEW This section details the marketing activities undertaken for BioPharma India Convention Samples of all promotional materials can be found in the appendices. Marketing of this event commenced as early as 12 months before the event. An integrated marketing plan combining the following was used in promoting BioPharma India Convention 2012: Direct mailing Print advertising Online banners and listings broadcasts Website Press releases Telemarketing

11 CONFERENCE MARKETING Direct Mail Direct mail is still a highly responsive media. For BioPharma India Convention 2012, a 10-page A4 size brochure detailing the 2 conference programs was produced. The conference mailings were targeted at senior decision makers from the relevant vertical industries found within Terrapinn s database. All sponsors and exhibitors which committed before the brochure printing deadline had their logos featured prominently within the brochure. (See Appendix A for brochure covers). Summary of direct mail campaign (brochure) Media type Distributed to Quantity Date 10PP conference brochure Terrapinn in-house database /8/2012 2PP postcard Terrapinn in-house database /10/2012 Mainstream and trade publications Print advertisements were placed in leading Life Science/Pharmaceutical-centric magazines as well as in mainstream media to generate publicity for the event between Aug 2012 and Nov (See Appendix B for sample ads). Summary of print advertising campaign Publication Dates Samanthi Publications P.Ltd 1/10/2012 Biopharm International 15/10/2012 PACRA 8/10/2012 Nature India 1/11/2012 JAIC 25/9/2012 Scientific American(sent ad) 20/10/2012 APBN 18/9/2012 Canbiotech 20/9/2012 BIoEquip 29/10/2012 Wicon Pharma China 24/10/2012 GEN 10/10/2012 Media publications that we worked with also did blasts, posted event listings on websites, and sent e-newsletters to their members to promote the event. (See Appendix C for sample event listings).

12 Summary of marketing activities via media publications Portal Samanthi Publications P.Ltd Pharmaceutical Research and Manufacturers Association (PReMA Biopharm International CCAMP PACRA Taipei Biotech Association Hungarian Bio Tech Antibodies.online Nature India JAIC Scientific American APBN Pharma Vision Canbiotech British pharmacological society BIoEquip Wicon Pharma China GEN Type of promotion Ad, blast blast Ad, Newsletter blast Ad, blast blast blast blast Ad, blast Ad, Newsletter, blast Ad, blast Ad, blast blast Ad, blast Social media facebook post Ad, blast blast Ad Summary of event listings

13 marketing An extensive campaign was executed for the event, involving 20 direct blasts. s with targeted messages were ed every week throughout May 2012 Nov 2012 to targeted groups. The always contained an link and a link direct to the event website. (See Appendix D for sample eshots). Telemarketing Our in-house team of telemarketers telephoned top clients and prospects over a five-month period. In total over 3,500 prospects were contacted by telephone Website A dedicated website for BioPharma India Convention 2012 was live for 12 months from Nov 2011 Nov The site contained details of the following: Updated conference program of the conference, summit, and masterclass Sponsors write up and logos that are hyperlinked to their website Speakers details Networking / Socials information Official media partners with web hyperlink Official association & research institute partners with web hyperlink Online registration Our unique networking system The site was updated on a weekly basis to keep customers informed of the changes and updates to the event. Designed to be user friendly, the website was a popular resource for interested prospective delegates - many of whom either registered directly or placed their enquiries online. The website address is featured prominently on all our conference brochures and other marketing collaterals used for promoting the event. Press and PR Prior to the event, press releases and clippings were prepared and media invites sent out to all foreign, local and mainstream press. Press which attended the event was: BioSpectrum India

14 Appendix A: Brochures Conference brochure A4, 10 pages

15 Postcard A5, 2 pages

16 Appendix B: Advertisements

17 Appendix C: Event Banners and Listings

18 Appendix D: Electronic mailers Internal HTML

19 External

20 Conference Attendee List Job Title Organization Country Business Manager - India Abbott Healthcare Pvt. Ltd. India Director - Medical Services Abbott Healthcare Pvt. Ltd. India Chief Executive Officer Accovion GmbH Germany Director American Medical Research, Inc. USA Global Product Manager, Bioprocess Group Asahi Kasei Medical Co., Ltd. Japan Representative Asahi Kasei Medical Co., Ltd. Singapore Head, Clinical Research & Development Astellas Pharma India Business Development Manager BAC B.V. Netherlands Chief Executive Officer BAC B.V. Netherlands Legal & IP Manager Battelle Science and Technology India Pvt Ltd India Director R&D BD Bioscience Singapore Business Manager Advanced BioProcessing BD Biosciences India Market Development Manager, Advanced BioProcessing Asia Pacific Region BD Biosciences Singapore Assistant Medical Director - CRA Bharat Biotech India Senior Vice President, Operations Bharat Serums & Vaccines India Deputy General Manager, R&D Biotech Bharat Serums And Vaccines Ltd India General Manager, R&D Biotech Bharat Serums And Vaccines Ltd India Senior Scientist, Cell Culture Biocon Limited India Correspondent BioSpectrumAsia India Director Board of Investment (BOI) Mauritius Vice President & Managing Director, Research & Development - India Bristol-Myers Squibb India Manager, Biotech Manufacturing Cadila Pharmaceutical Ltd. India Director, Healthcare & Life Sciences CDS K. K. Japan Head, Glycomics and Glycoproteomics Centre for Cellular and Molecular Platforms India

21 Director & Chief Operating Officer Centre for Cellular and Molecular Platforms India Head of Medical Services Cipla India Group Leader Cipla Ltd India Area Director, India Contact Singapore India Manager, Production Dr. Reddy's Laboratories Ltd. India Senior Director & Head, Merck Serono Alliance Dr. Reddy's Laboratories Ltd. India Director, Healthcare Sales India Envirotainer AB Sweden Asia Pacific Sales Manager Finesse Solutions, LLC Singapore Cell Nutrition Scientist FrieslandCampina Domo USA R&D Manager Cell Nutrition FrieslandCampina DOMO The Netherlands Regional Sales Manager FrieslandCampina Domo Singapore Business Development Manager GE Healthcare Singapore Global Sales Leader Powder Media GE Healthcare Europe GmbH Germany General Manager, Bioprocess Life Sciences GE Healthcare Life Sciences India General Manager-West GE Healthcare Life Sciences India Managing Director, Life Sciences GE Healthcare Life Sciences India Marketing Manager GE Healthcare Life Sciences India Global Commercial Leader GE Healthcare, Life Sciences India Business Manager - Bioseparation Division Genetix Biotech Asia Pvt. Ltd. India Chief Executive Officer Genetix Biotech Asia Pvt. Ltd. India director, Business Development Genetix Biotech Asia Pvt. Ltd. India Assistant General Manager, Regulatory Affairs Gennova Biopharmaceuticals Limited India Senior Manager, Manufacturing Gennova Biopharmaceuticals Limited India Principal Scientist Gennova Vaccine Formulation Centre and India Research Lab Senior Director, Analytical Development Genzyme-Sanofi USA Head - Biologics Operations Hetero Drugs Ltd India Vice President, Business Development Hyde Engineering & Consulting India

22 Managing Director, Asia Pacific Hyde Engineering & Consulting India Pvt Ltd India Deputy Managing Director Indian Immunologicals Limited India Narotam Sekhsaria Distinguished Professor, Chemical Engineering Institute of Chemical Technology Mumbai India Vice President Intas BioPharma India Principal Scientist, Downstream Intas Biopharmaceuticals Ltd. India Senior Scientist I, Drug Product Development Intas Biopharmaceuticals Ltd. India Head EHS & UK & APAC Operations Intertek Switzerland Business Development Manager Intertek India Pvt. Ltd. India Head, Intertek Expert Services, India Intertek India Pvt. Ltd. India Senior Team Leader, Analytical Intertek, ASG India Marketing Manager Invitrogen BioServices India Pvt. Ltd. India President, Medical Affairs & Clinical Research Ipca Laboratories India Assistant Manager, Clinical Research & Development Ipca Laboratories Ltd India Group Leader, Biologic Manufacturing Kemwell Biopharma Pvt Ltd India Senior Director, Operations (Biologics) Kemwell Biopharma Pvt Ltd India Senior Group Leader, Manufacturing Kemwell Biopharma Pvt Ltd India Account Manager - Cell Nutrition India Kerry Ingredients & Flavours India Professor King Fahad Medical City Saudi Arabia Business Development Manager - POROS Life Technologies India Head, POROS Business and Global Applications BioProduction Life Technologies USA Senior Product Manager, Pharma Analytics division Life Technologies India Technical Sales Specialist Life Technologies India Technical Sales Specialist (TSS) BioProdution Life Technologies India Global Commercial Leader Life Technologies USA Director Lisaline Lifescience Technologies Pvt. Ltd. India Manager - Manufacturing Lupin Limited (Biotech Division) India Principal Scientist, Biotechnology R&D Lupin Limited (Biotech Division) India Team Lead - PSURs and Risk Management Plan Lupin Pharma India

23 President, Biotech Lupin Pharmaceuticals India Director Industrial Operations M/S Popular Pharmaceuticals Ltd. Bangladesh Manager - Cell Biology MabPharm Pvt. Ltd. (a Subsidiary of Cipla) India Chief Operating Officer, Biobank Graz Medizinische Università t Graz Austria Executive Director, Head of Strategic Licensing and Acquisitions Merck USA Senior Associate - Clinical Research Merck Ltd India Director of Biomanufacturing Sciences Network for Asia Merck Millipore India Head Biopharm Process Solutions India Merck Millipore India Regional Manager - BioPharm Process Solutions Merck Millipore India Sales Manager - BPS Merck Millipore India Senior Associate, Clinical Research, Oncology Merck Specialities Pvt. Ltd. India Group Manager Field Marketing Millipore (India) Pvt. Ltd. India Director, Licensing & External Research MSD Australia Australia Sales Director, APAC OCASA Inc. Australia Chief Executive Officer Orgenesis Inc. USA Business Development Manager PAA Laboratories - GE Healthcare India Vice President, Biopharmaceutical Asia Pall Corporation Singapore Marketing Applications Scientist Pall ForteBio India Director, Biopharm India Pall India Pvt. Ltd. India Manager, Biotech Pall India Pvt. Ltd. India Managing Director, Pall India Pall India Pvt. Ltd. India Marketing Manager-Biopharma Pall India Pvt. Ltd. India Marketing Manager-Biopharma Pall India Pvt. Ltd. India Technical Lead, SLS BioPharm Asia Pall India Pvt. Ltd. India General Manager Panacea Biotec India Vice President, International Formulation Panacea Biotec India Assistant Manager, Toxicology Panacea Biotec Ltd India Scientist, Biopharmaceutical (R&D) Panacea Biotec Ltd India

24 Customer Strategist Parexel Consulting United Kingdom Executive Director, Product Marketing Perkin Elmer USA Informatics Division BSG Technical Manager, Bio-Manufacturing Sciences, India Pfizer Pharmaceutical India Pvt. Ltd. India General Manager- Clinical Development Piramal Healthcare India Senior Director, Clinical Development, Clinical Research and Development Piramal Healthcare India General Manager - Corporate Regulatory Affairs Piramal Life Sciences India Assistant Director Natural Products Fermentation Piramal Life Sciences Ltd. India Assistant General Manager, Business Development Piramal Life Sciences Ltd. India Junior Research Scientist - Fermentation Technology Piramal Life Sciences Ltd. India Junior Research Scientist - Fermentation Technology Piramal Life Sciences Ltd. India Senior Research Scientist - Natural Products Piramal Life Sciences Ltd. India EMEA Sales & Marketing Director Prometic Biosciences Ltd United Kingdom Chief Business Officer PROXY Laboratories B.V. Netherlands Associate Director, Site Management Clinical Operations Quintiles India Associate Medical Director, Asia Medical Sciences Quintiles India Chief Executive Officer Realization USA Sales Manager Realization Technologies, Inc. India Asssitant Vice President and Head, Regulatory Affairs Reliance Life Sciences India Head of Business Development Reliance Life Sciences India Head of Business Development - Clinical Research Services Reliance Life Sciences India President & CEO Reliance Life Sciences India Research Leader Reliance Life Sciences India Research Leader, Therapeutic Proteins Group Reliance Life Sciences India Senior Principal Scientist & Team Lead - Upstream Process Development Reliance Life Sciences India Vice President, Sales & Marketing Repligen Corporation USA Managing Director, India RGF India India Director, Regulatory Affairs Sanofi Aventis India

25 Associate Director, Medical Affairs and Strategy Implementation Sanofi Pasteur India Manager, Regulatory Affairs - CSU Sanofi Synthelabo India Senior Director External Mfg, Asia Pacific Japan Sanofi Synthelabo Ltd. India Head of Biotech Process & Application Support Sartorius India Pvt Ltd India Head of Business Development Integrated Solutions Sartorius India Pvt Ltd India Vice President, Purification Technologies Sartorius Stedim Biotech GmbH Germany Additional Director Serum Institute of India India Director Vaccine Production Serum Institute of India India Executive Director Serum Institute of India India Deputy Manager, Research & Development Serum Institute of India Ltd India Senior Manager, Research & Development Serum Institute of India Ltd India Chief Clinical Officer and Chief PV & COA Officer Shantha Biotechnics India Principal Scientist and Head, Downstream Process, Manufacturing Technologies Shantha Biotechnics India Deputy General Manager - Operations, Biotech Shasun Pharmaceuticals Limited India Head of the Bert Strassburger, Lipid Center Sheba Medical Center Israel Marketing Director SHL Group India Marketing Director SHL Group Taiwan Project Manager, Marketing Department SHL Group Taiwan Center Director Singapore Economic Development Board India Corporate Marketing Specialist Springer SBM B.V. Netherlands COO Stabilitech Limited United Kingdom General Manager, Clinical Research Sun Pharma India Director,Process Development Syngene International India Head, Biologics Operations Syngene International India Director Tech-Excel India Associate Technical Director Asia Pacific, Field Applications and Cell Culture Thermo Fisher Scientific India Associate Director Product Management Thermo Fisher Scientific India Pvt. Ltd. India Director, Laboratory Products Group Thermo Fisher Scientific India Pvt. Ltd. India

26 General Manager Thermo Fisher Scientific India Pvt. Ltd. India Marketing Director, APAC, BPP Thermo Fisher Scientific India Pvt. Ltd. India Senior Global Product Manager Thermo Fisher Scientific India Pvt. Ltd. India Sr. Executive-MarCom Thermo Fisher Scientific India Pvt. Ltd. India Sales Executive Tosoh Asia Pte. Ltd. Singapore General Manager, Pilot Plant (Biotechnology) Unichem Laboratories India Australian Research Council Research Fellow University of Sydney Australia Associate Professor University of the Philippines Manila Philippines Associate Professor University of the Philippines Manila Philippines Associate Professor University of the Philippines Manila Philippines Research Associate University of the Philippines Manila Philippines Senior Manager, Production Biologics Research USV Ltd India Director, Business Development Asia Vetter Pharma International GmbH Germany Deputy General Manager, Clinical Operations Watson Pharma Pvt Ltd India Manager-Clinical Data Management Wockhardt Limited India Research Associate Wockhardt Limited India Vice President, Manufacturing Wockhardt Limited India Business Development Consultant WuXi AppTec Inc. USA Head Healthcare Youbook Pte Ltd Singapore Manager Zydus Cadila India Senior Manager and Head, Viral Vaccines Development Zydus Cadilla India

27 About Terrapinn Terrapinn, as a specialized B2B conference organizer with 18 years global experience, has developed a high quality and proprietary method of creating the very best conference programmes for senior level decision-makers. Research, undertaken throughout the year by way of face to face and telephone interviews with senior industry executives, sets the conference agenda whilst attracting the highest level of speakers to our programmes. We do not believe in vendor-led, low value seminars. Our conference programmes are based on the complex needs of high level end-user executives Backed by a worldwide network, our 6 offices across Singapore, Australia, United Kingdom, Africa, the Middle East and the Americas, are dedicated research centres with regional marketing knowledge and a strong database. We pride ourselves on the quality of our events and the professionalism and effectiveness of our marketing. Terrapinn conferences, trade shows and award ceremonies are the industry standard for the sectors they serve. Each year the company produces over 200 events across the world: in Asia Pacific, in Europe, in Africa, in the Middle East, in the Americas. For further details or customised packages, please contact: Renee Tan Project Director DID: renee.tan@terrapinn.com Rebecca Koh Project Director DID: rebecca.koh@terrapinn.com